Back
Editas Medicine Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
61
EDIT
Editas Medicine
Last Price:
$3.06
Seasonality Move:
-11.1%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight buying pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.54 | Buy |
20-day SMA: | 2.31 | Buy |
50-day SMA: | 1.89 | Buy |
200-day SMA: | 2.01 | Buy |
8-day EMA: | 1.18 | Buy |
20-day EMA: | 0.54 | Buy |
50-day EMA: | 0.23 | Buy |
200-day EMA: | 0.06 | Buy |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 75.78 | Buy |
Chaikin Money Flow: | 86246 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.91 - 2.53) | Buy |
Bollinger Bands (100): | (1.24 - 2.12) | Buy |
Editas Medicine Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 3.08 while EDIT 8-day simple moving average is 2.54, which is a Buy signal.
-
The stock price of EDIT is 3.08 while Editas Medicine 20-day SMA is 2.31, which makes it a Buy.
-
Editas Medicine 50-day simple moving average is 1.89 while EDIT share price is 3.08, making it a Buy technically.
-
EDIT stock price is 3.08 and Editas Medicine 200-day simple moving average is 2.01, creating a Buy signal.
EDIT Technical Analysis vs Fundamental Analysis
Buy
61
Editas Medicine (EDIT)
is a Buy
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a BuyThe current Editas Medicine [EDIT] share price is $3.08. The Score for EDIT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Editas Medicine Stock Info
Market Cap:
257.8M
Price in USD:
3.08
Share Volume:
5.6M
Editas Medicine 52-Week Range
52-Week High:
6.05
52-Week Low:
0.91
Buy
61
Editas Medicine (EDIT)
is a Buy
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 3.08 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is not overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 3.08 while EDIT 8-day exponential moving average is 1.18, which is a Buy signal.
-
The stock price of EDIT is 3.08 while Editas Medicine 20-day EMA is 0.54, which makes it a Buy.
-
Editas Medicine 50-day exponential moving average is 0.23 while EDIT share price is 3.08, making it a Buy technically.
-
EDIT stock price is 3.08 and Editas Medicine 200-day simple moving average is 0.06, creating a Buy signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.08 per share, an increase this year of $0.82 per share, and an increase next year of $0.69 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.42, suggesting Editas Medicine is a Buy
-
Editas Medicine Relative Strength Index (RSI) is 75.78, which suggest Editas Medicine is overbought
-
The Bollinger Bands (25) for Editas Medicine is (1.91 - 2.53), which suggest Editas Medicine is a Buy
-
The Bollinger Bands (100) for Editas Medicine is (1.24 - 2.12), which suggest Editas Medicine is a Buy
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.